Washington State Senate
(WA Senate)

Legislators were making steady progress on 29 active cannabis-related bills, having heard five on Monday with plans to hear two more on Tuesday along with four executive sessions.

A bill adding restrictions on manufacturing and sales of hemp cannabinoid products was generally well received, but many speakers disagreed with the allowable THC limits.

Hearings on WSLCB THC legislation, cannabis waste, advertising, low dose products, patient arrest protections, local override, home grow, and the fate of concentrates were all scheduled.

Senators heard supportive testimony on a bill addressing retail theft and four new bills were prepared for introduction, including two targeting concentrated cannabis products.

Interstate commerce was moved to the Senate floor, the policy committee in the senate planned to take action, two bills were set for introduction, and next week’s schedule was announced.

The out-of-state ownership bill was heard, two seasoned bills were set for introduction, and medical cannabis patients would make their case for excise tax exemption in 2023.

Legislators continued to undertake cannabis bills slowly, especially in the senate, but perennial subjects like out-of-state ownership had been positioned for consideration.

Patients would get another chance at excise tax exemption, WSLCB leadership prepared to tell their 502 story, and only two cannabis bills were scheduled for action the following week.

Interstate commerce legislation was advanced in the Senate but delayed in the House, and cannabis packaging law changes drew support from the advocates who showed up.

The committee approved interstate cannabis commerce legislation and sent it to the chamber’s Rules Committee where it would await action on other cannabis bills.